CN1543350A - 糖半抗原和聚集的蛋白载体的免疫原性结合物 - Google Patents

糖半抗原和聚集的蛋白载体的免疫原性结合物 Download PDF

Info

Publication number
CN1543350A
CN1543350A CNA028160711A CN02816071A CN1543350A CN 1543350 A CN1543350 A CN 1543350A CN A028160711 A CNA028160711 A CN A028160711A CN 02816071 A CN02816071 A CN 02816071A CN 1543350 A CN1543350 A CN 1543350A
Authority
CN
China
Prior art keywords
conjugate
hapten
carrier
moiety
aldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028160711A
Other languages
English (en)
Chinese (zh)
Inventor
����ˡ�J������˹
马克·J·克兰茨
��B���ʸ��ڿ�
迈克尔·B·朗格内克
R���Ƹ�̩
拉奥·R·科根泰
希廷翁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncothyreon Canada Inc
Original Assignee
Biomira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Inc filed Critical Biomira Inc
Publication of CN1543350A publication Critical patent/CN1543350A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/001172—Sialyl-Thomson-nouvelle antigen [sTn]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CNA028160711A 2001-08-14 2002-08-05 糖半抗原和聚集的蛋白载体的免疫原性结合物 Pending CN1543350A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31185001P 2001-08-14 2001-08-14
US60/311,850 2001-08-14

Publications (1)

Publication Number Publication Date
CN1543350A true CN1543350A (zh) 2004-11-03

Family

ID=23208785

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028160711A Pending CN1543350A (zh) 2001-08-14 2002-08-05 糖半抗原和聚集的蛋白载体的免疫原性结合物

Country Status (6)

Country Link
US (1) US20040247608A1 (cg-RX-API-DMAC7.html)
EP (1) EP1429785A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005526692A (cg-RX-API-DMAC7.html)
CN (1) CN1543350A (cg-RX-API-DMAC7.html)
CA (1) CA2454853A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003015796A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102276662A (zh) * 2010-06-09 2011-12-14 北京大学 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用
CN106526188A (zh) * 2016-11-09 2017-03-22 百奥森(江苏)食品安全科技有限公司 一种食品中沙丁胺醇的检测试剂盒
CN106645697A (zh) * 2016-11-09 2017-05-10 百奥森(江苏)食品安全科技有限公司 一种食品中玉米赤霉醇的检测试剂盒

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080081045A1 (en) * 2003-10-14 2008-04-03 Biomira, Inc. Combination Therapy for Cancer
EP3046588B1 (en) 2013-09-17 2022-03-02 OBI Pharma, Inc. Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
MY188880A (en) * 2014-09-15 2022-01-12 Obi Pharma Inc Immunogenic/therapeutic glycoconjugate compositions and uses thereof
EP3344806A4 (en) 2015-09-04 2019-03-20 OBI Pharma, Inc. GLYCANARRAYS AND METHOD OF USE
AU2017239637A1 (en) 2016-03-29 2018-11-15 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
US10980894B2 (en) 2016-03-29 2021-04-20 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
IL262296B2 (en) 2016-04-22 2024-09-01 Obi Pharma Inc Cancer immunotherapy by immune activation or immune modulation via globo series antigens
KR20190067765A (ko) 2016-07-27 2019-06-17 오비아이 파머 인코퍼레이티드 면역원성/치료 글리칸 조성물 및 그의 용도
KR102528998B1 (ko) 2016-07-29 2023-05-03 오비아이 파머 인코퍼레이티드 인간 항체, 제약 조성물 및 방법
WO2018094414A1 (en) 2016-11-21 2018-05-24 Obi Pharma, Inc. Conjugated biological molecules, pharmaceutical compositions and methods
TW202504930A (zh) 2018-06-27 2025-02-01 台灣浩鼎生技股份有限公司 用於糖蛋白工程的糖苷合成酶變體及其使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407912A (en) * 1993-04-19 1995-04-18 Akzo, N.V. Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity
AU2247095A (en) * 1994-04-12 1995-10-30 Biomira Inc. Cellular immune response-specific antigens and uses therefor
WO1995029927A2 (en) * 1994-05-02 1995-11-09 Biomira, Inc. Process for preparation of glycosides of tumor-associated carbohydrate antigens
EP1091751A4 (en) * 1998-03-25 2005-01-19 Sloan Kettering Institutefor C TRIMERIC OXYGENIC BINDING GLYCOPEPTIDE CONJUGATES, METHODS OF PREPARATION AND USE THEREOF

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102276662A (zh) * 2010-06-09 2011-12-14 北京大学 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用
WO2011153815A1 (zh) * 2010-06-09 2011-12-15 北京大学 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用
CN102276662B (zh) * 2010-06-09 2014-05-14 北京大学 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用
US9695208B2 (en) 2010-06-09 2017-07-04 Peking University Sialic acid (A-(2-6))-D-aminopyranose derivatives, synthesis methods and uses thereof
CN106526188A (zh) * 2016-11-09 2017-03-22 百奥森(江苏)食品安全科技有限公司 一种食品中沙丁胺醇的检测试剂盒
CN106645697A (zh) * 2016-11-09 2017-05-10 百奥森(江苏)食品安全科技有限公司 一种食品中玉米赤霉醇的检测试剂盒

Also Published As

Publication number Publication date
JP2005526692A (ja) 2005-09-08
EP1429785A1 (en) 2004-06-23
CA2454853A1 (en) 2003-02-27
WO2003015796A1 (en) 2003-02-27
EP1429785A4 (en) 2005-12-14
US20040247608A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
CN1279971C (zh) 下调淀粉状蛋白的新方法
CN1150318C (zh) 用于预防或治疗恶性肿瘤的HER-2/neu蛋白胞内区
CN1249085C (zh) 诱导对β淀粉状蛋白和淀粉状蛋白沉积物的免疫反应、与β淀粉状蛋白同源的免疫源性但非淀粉状蛋白源性合成肽
CN1096032A (zh) 新的活性化合物
HK1048937A1 (zh) 下调gdf-8活性的方法
CN1291235A (zh) 疫苗、免疫治疗剂及其应用方法
CN1805758A (zh) 核酸和细胞疫苗的组分
CN1921878A (zh) 属于Bcl-2家族的蛋白和其片段,和它们在癌症患者中的用途
CN1902227A (zh) Tim-3配体及其方法
CN1515672A (zh) 人类趋化因子β-8,趋化因子β-1和巨噬细胞炎性蛋白-4
CN1194000A (zh) 增强保护性免疫应答的方法
CN1253471C (zh) Cc型趋化因子样蛋白质
CN1761756A (zh) 禽类物种中内源性原生殖细胞的耗减
US20040247608A1 (en) Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
CN1509337A (zh) IFNα-17基因的新的多核苷酸和多肽
CN1158387C (zh) 编码l.infantum的四种蛋白质的抗原决定簇的嵌合基因
CN1680434A (zh) 肺炎链球菌抗原
CN1849395A (zh) 来源于Livin的HLA-A24结合性癌抗原肽
CN1639569A (zh) 诱导免疫应答的方法和组合物
CN101052718A (zh) 变异型淀粉样蛋白质
CN1157621A (zh) 用于检测和治疗i型糖尿病的胰岛素原肽化合物
CN1910284A (zh) 由HLA-A2402-限制的Ep-CAM-特异的CTL识别的表位/肽及其应用
CN1112127A (zh) 新的蛋白质p140多肽及编码该多肽的DNA
CN1214692A (zh) 由hla-b44分子呈递的肿瘤排斥抗原及其应用
CN1893970A (zh) β-淀粉样蛋白-类似物-T-细胞表位疫苗

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication